MILRINONE Side Effects

7004851-9 | Atrial Fibrillation
on Sep 10, 2010 Female patient from CHINA , 70 years of age, was diagnosed with hypertension, infection (What is infection?) and was treated with Milrinone (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Milrinone dosage: . During the same period patient was treated with FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ETIMICIN (View Etimicin Review and Etimicin Label ).

6999450-9 | Atrial Fibrillation
Patient was taking Milrinone (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Sep 07, 2010 from CHINA Additional patient health information: Female patient , 70 years of age, was diagnosed with hypertension and. Milrinone dosage: . During the same period patient was treated with FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ).

6636604-5 | Pulmonary Embolism, Pulmonary Hypertension, Right Ventricular Hypertrophy, Tricuspid Valve Incompetence
Adverse event was reported on Mar 03, 2010 by a Female patient taking Milrinone (View Usage) (Dosage: 0.4mcg/kg/min.) was diagnosed with mean arterial pressure, pulmonary hypertension (What is pulmonary hypertension?), ventricular failure, ventricular dysfunction and. Location: UNITED KINGDOM , 16 years of age, weighting 110.2 lb, After Milrinone was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?), pulmonary hypertension (What is pulmonary hypertension?), right ventricular hypertrophy, tricuspid valve incompetence. During the same period patient was treated with ADRENALINE (0.4mcg/kg/min) (View Adrenaline Review and Adrenaline Label ), DOBUTAMINE HCL (5.5mcg/kg/min) (View Dobutamine Hcl Review and Dobutamine Hcl Label ), NORADRENALINE (0.3mcg/kg/min) (View Noradrenaline Review and Noradrenaline Label ), SILDENAFIL CITRATE (1 Mg/hr) (View Sildenafil Citrate Review and Sildenafil Citrate Label ), VASOPRESSIN INJECTION (2.4 I.u/hr.) (View Vasopressin Injection Review and Vasopressin Injection Label ). Patient was hospitalized.

6600025-1 |
on Feb 16, 2010 Female patient from UNITED KINGDOM , 16 years of age, weighting 110.2 lb, was diagnosed with mean arterial pressure, pulmonary hypertension (What is pulmonary hypertension?), ventricular failure, ventricular dysfunction and was treated with Milrinone (View Usage). . Milrinone dosage: 0.4mcg/kg/min.. During the same period patient was treated with ADRENALINE (0.4mcg/kg/min) (View Adrenaline Review and Adrenaline Label ), DOBUTAMINE (5.5mcg/kg/min) (View Dobutamine Review and Dobutamine Label ), NORADRENALINE (0.3mcg/kg/min) (View Noradrenaline Review and Noradrenaline Label ), SILDENAFIL CITRATE (1 Mg/hr) (View Sildenafil Citrate Review and Sildenafil Citrate Label ), VASOPRESSIN INJECTION (2.4 I.u/hr.) (View Vasopressin Injection Review and Vasopressin Injection Label ). Patient was hospitalized.


6170381-X | Platelet Count Decreased
on Apr 27, 2009 Male patient from UNITED STATES , weighting 187.0 lb, was diagnosed with cardiac failure acute and was treated with Milrinone (View Usage). Patient had the following side effects: platelet count decreased. Milrinone dosage: 0.125-0.25 Mcg/kg/min. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), APAP TAB (View Apap Tab Review and Apap Tab Label ), MAALOX (View Maalox Review and Maalox Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), MEPERIDINE HCL (View Meperidine Hcl Review and Meperidine Hcl Label ), MORPHINE (View Morphine Review and Morphine Label ), PERCOCET (View Percocet Review and Percocet Label ).

6077862-8 | Overdose
Patient was taking Milrinone (View Usage). After Milrinone was administered, patient had the following side effects: overdose on Sep 30, 2004 from UNITED STATES Additional patient health information: Female patient , child 4 years of age, . Milrinone dosage: . Patient was hospitalized.

5599685-6 | Hypotension
Adverse event was reported on Jan 18, 2008 by a Female patient taking Milrinone (View Usage) (Dosage: 0.96mcg/kg/min Iv) . Location: UNITED STATES , 66 years of age, weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: hypotension.

5415652-7 | Azotaemia, Blood Pressure Decreased, Catheter Site Haemorrhage, Device Failure, Hepatic Necrosis, Multi-organ Failure, Pneumothorax, Renal Failure, Septic Shock
on Aug 07, 2007 Male patient from UNITED STATES , 18 years of age, was treated with Milrinone (View Usage). Patient had the following side effects: azotaemia, blood pressure decreased, catheter site haemorrhage, device failure, hepatic necrosis, multi-organ failure, pneumothorax, renal failure, septic shock. Milrinone dosage: . During the same period patient was treated with HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% (View Heparin Sodium 1,000 Units And Sodium Chloride 0.9% Review and Heparin Sodium 1,000 Units And Sodium Chloride 0.9% Label ), TAZICEF (View Tazicef Review and Tazicef Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), SULCONAZOLE (View Sulconazole Review and Sulconazole Label ), PEPCID (View Pepcid Review and Pepcid Label ), VASOPRESSIN (View Vasopressin Review and Vasopressin Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ).

5385470-7 | Hypotension, Palpitations, Ventricular Extrasystoles
on Jul 06, 2007 Male patient from UNITED STATES , 77 years of age, was diagnosed with cardiac failure congestive and was treated with Milrinone (View Usage). After Milrinone was administered, patient had the following side effects: hypotension, palpitations, ventricular extrasystoles. Milrinone dosage: 0.375mcg/kg/min Cont Infusion Iv. Patient was hospitalized.

5377119-4 | Ventricular Extrasystoles
Patient was taking Milrinone (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular extrasystoles on Jun 29, 2007 from UNITED STATES Additional patient health information: Male patient , 77 years of age, was diagnosed with cardiac failure congestive and. Milrinone dosage: 0.375mcg Every Day Iv. Patient was hospitalized.

5316827-8 | Palpitations, Ventricular Extrasystoles
Adverse event was reported on May 01, 2007 by a Male patient taking Milrinone (View Usage) (Dosage: 0.375 Other Iv) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 77 years of age, Patient had the following side effects: palpitations, ventricular extrasystoles.

4723425-3 | Ventricular Extrasystoles, Ventricular Fibrillation, Ventricular Tachycardia
on Jul 21, 2005 Female patient from UNITED STATES , 78 years of age, was diagnosed with cardiogenic shock and was treated with Milrinone (View Usage). After Milrinone was administered, patient had the following side effects: ventricular extrasystoles, ventricular fibrillation, ventricular tachycardia. Milrinone dosage: .

4669176-5 | Atrial Fibrillation, Hypotension
on Apr 27, 2005 Female patient from , 79 years of age, was diagnosed with cardiac failure and was treated with Milrinone (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), hypotension. Milrinone dosage: 0.25 Mcg/kg Per Minute/0.2 Mcg/kg Per Minute/0.1 Mcg/kg Per Minute; Inj.

4653977-3 | Atrial Fibrillation, Hypotension
Patient was taking Milrinone (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), hypotension on Apr 27, 2005 from Additional patient health information: Female patient , 79 years of age, was diagnosed with cardiac failure, mitral valve repair and. Milrinone dosage: 0.25 Mcg/kg Per Minute/0.2 Mcg/kg Per Minute/0.1.

4622654-7 | Neonatal Disorder, Procedural Hypertension
Adverse event was reported on Mar 28, 2005 by a Male patient taking Milrinone (View Usage) (Dosage: 1 Mcg/kg/min) was diagnosed with surgery (What is surgery?), transposition of the great vessels and. Location: , child 7 years of age, weighting 7.94 lb, After Milrinone was administered, patient had the following side effects: neonatal disorder, procedural hypertension.